Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: A case control study

National Medical Journal of China

Volumn 89, Issue 1, 2009, Pages 37-40

  Wang, Tao ^a   Xiao, Shi Fu ^a   Li, Xia ^a   Wang, Ying ^a   Ding, Bei ^a   Ling, Hua Wei ^a   Chen, Ke Min ^a  

^a NONE

Author keywords

Alzheimer disease; Cognition; Dementia, vascular; Magnetic resonance spectroscopy

Indexed keywords

CREATINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID;

ALCOHOL BLOOD LEVEL; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EDUCATIONAL STATUS; GENDER; HUMAN; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PREDICTIVE VALIDITY; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; RATING SCALE; AGED; FEMALE; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION; DEMENTIA, VASCULAR; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 77954827242     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.01.010     Document Type: Article

References (12)

1. Atlas SW. Magnetic resonance imaging of the brain and spine. 3rd edition. New York: Philadelphia Lippincott Williams and Wilkins, 2002: 1189.
2. Waldman AD, Rai GS, McConnell JR, et al. Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people. Arch Gerontol Geriatr, 2002, 35: 137-142.
3. Vogt BA, Finch DM, Olson CK. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex, 1992, 2: 435-443.
4. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology, 2001, 56: 592-598.
5. Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry, 2003, 160: 2003-2011.
6. Kantarci K, Reynolds G, Petersen RC, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer's disease: comparison of 1.5T and 3T. AJNR, 2003, 24: 843-849.
7. Kantarci K, Smith GE, Ivnik RJ, et al. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neurepsychol Soc, 2002, 8: 934-942.
8. Waldman AD, Bai GS. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology, 2003, 45: 507-512.
9. MacKay S, Ezekiel F, Di Sclafan V, et al. Alzheimer's disease and subcortical ischemic vaseular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology, 1996, 198: 537-545.
10. Kantarci K, Jack CR, Xu Y, et al. Regional metabolic patterns in mild cognitive impairment and alzheimer's disease: a H-MRS study. Neurology, 2000, 55: 210-217.
11. Griffith HR, den Hollander JA, Stewart CC, et al. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease. NMR Biomed, 2007, 20: 709-716.